We've found
9,144
archived clinical trials in
Ocular
We've found
9,144
archived clinical trials in
Ocular
Rate of Progression in USH2A Related Retinal Degeneration
Updated: 12/31/1969
Rate of Progression in USH2A Related Retinal Degeneration
Status: Enrolling
Updated: 12/31/1969
Rate of Progression in USH2A Related Retinal Degeneration
Updated: 12/31/1969
Rate of Progression in USH2A Related Retinal Degeneration
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Rate of Progression in USH2A Related Retinal Degeneration
Updated: 12/31/1969
Rate of Progression in USH2A Related Retinal Degeneration
Status: Enrolling
Updated: 12/31/1969
Rate of Progression in USH2A Related Retinal Degeneration
Updated: 12/31/1969
Rate of Progression in USH2A Related Retinal Degeneration
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Rate of Progression in USH2A Related Retinal Degeneration
Updated: 12/31/1969
Rate of Progression in USH2A Related Retinal Degeneration
Status: Enrolling
Updated: 12/31/1969
Rate of Progression in USH2A Related Retinal Degeneration
Updated: 12/31/1969
Rate of Progression in USH2A Related Retinal Degeneration
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Rate of Progression in USH2A Related Retinal Degeneration
Updated: 12/31/1969
Rate of Progression in USH2A Related Retinal Degeneration
Status: Enrolling
Updated: 12/31/1969
Rate of Progression in USH2A Related Retinal Degeneration
Updated: 12/31/1969
Rate of Progression in USH2A Related Retinal Degeneration
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Updated: 12/31/1969
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Updated: 12/31/1969
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials